BMSN Doubles – Major News Out
pennystocksvip Newsletter
If you are having trouble viewing this message, [1]see it in your browser.
BMSN Reaches +40% For Us In Minutes Only Fellow Members, I very much hope you were listening this morning when I told you about being quick. If you have, then you must have made another 40% today. BMSN opened up at $0.034 and went on to $0.047 that alone is 40% in a few minutes of work. BMSN still looks attractive with prices stabilizing at $0.042. What do you think happens when traders and investors read the news about BMSN and see how hot a trade it has been in the first 30 minutes.
If you missed my alert, read it here:
Now let us get on with Today`s Pick: BMSN.PK – Bio-Matrix Scentific Group.
Before I tell you about the company, read this first:
[2]Bio-Matrix Scientific Group, Inc. Announces Newly Formed Stem Cell Subsidiary — Regen BioPharma Inc., Secures $20M in Institutional Funding Yes, You read that right, today`s pick is going to be very hot. The Company just announced a 20M financing. More even ! Institutional Funding. These kinds of funds and financing is usually the result of months of due dilligence and reviews by top analysts at the institution or firm. So what this tells me is that this institution saw something worth pouring $20M into BMSN.
Now Let me tell you a little more about today`s pick.
BMSN is a biotechnology company focused on the development of regenerative medicine therapies and tools. The Company is specifically focused on human therapies that address unmet medical needs. Specifically, Bio-Matrix Scientific Group Inc. is looking to increase the quality of life through therapies involving stem cell treatments. These treatments are focused in areas relating to lung, heart, circulatory system and other internal organs.
BMSN is headquartered in San Diego, Ca. with a 15,000 sq. ft.
facility that houses two secure cryogenic stem cell banks, three research laboratories, aseptic cellular/tissue class 10,000/100 processing lab, hematology, microbiology and flow cytometry laboratories.
Biotech companies are very hot right now. I have been following a great many of them and can`t say that it seems like the interest for Biotech Companies is fading.
Typically I have seen this kinds of picks explode when an FDA approval or a clinical trial is concluded. Now here is where today`s news and BMSN`s newly formed Stem Cell Subsidiary is so interesting. The Company is assembling the team and capabilities to in-license and evaluate technologies rapidly, then to develop the regulatory package and initiate clinical trials. Their business model and partnerships will allow BMSN to take cell therapy products from discovery to FDA Phase II clinical trials in as short a period as 18 – 24 months.
So Don`t Snooze Guys, let`s be quick about this one, this could be a runner.
Oh, and don`t forget ! Join my SMS Alert service, It`s Free and it gets you the alerts way faster so you can get in way earlier.
Link: [3]FREE SMS Alert Service Form or Text VIPStocks to 69302 Sincerely Penny Stocks VIP This message sent to by info@pennystocksvip.com Investor Alley Inc. 1200 McGill College Avenue Suite 1100 Montreal, Quebec H3B 4G7 You opted in to this list from: Subscribed Through PennyStocksVIP.com ([4]More info) [5]
Related posts:
- Could APPH Hit $1.02? Based on Analyst Report!
- Today 7PM (EST) This changes EVERYTHING….
- Announced- FGLD (Timing is Critical) Open Now…
- BZRT (News Out) Volume and Price Surging
- Told ya So (FTEG) Volume Surging – Break out